MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) was the target of a large increase in short interest in August. As of August 14th, there was short interest totaling 17,636 shares, an increase of 1,668.9% from the July 30th total of 997 shares. Based on an average trading volume of 132,170 shares, the days-to-cover ratio is currently 0.1 days.
MediPharm Labs Trading Down 1.1%
MEDIF stock opened at $0.06 on Thursday. MediPharm Labs has a fifty-two week low of $0.04 and a fifty-two week high of $0.08. The business’s 50 day moving average price is $0.05 and its two-hundred day moving average price is $0.05.
MediPharm Labs Company Profile
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- J.M. Smucker’s Rally Nears a Key Test: Is a Full Recovery Ahead?
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
